RLMD FRAUD ALERT: Jakubowitz Law is Investigating Relmada Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws

Posted on by

NEW YORK, May 5, 2023 /PRNewswire/ — Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Relmada Therapeutics, Inc. (NYSE: RLMD) To be contacted by a member of our team, fill out the form:…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.